The influence of low molecular weight heparin medication on plasma DNA in pregnant women

E-ISSN： 1097-0223|35|11|1155-1157

ISSN： 0197-3851

Source： PRENATAL DIAGNOSIS, Vol.35, Iss.11, 2015-11, pp. : 1155-1157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of an Optimal Dose of Low-Molecular-Weight Heparin for Thromboprophylaxis in Pregnant Women at Risk of Thrombosis Using Coagulation Activation Markers

Pathophysiology of Haemostasis and Thrombosis, Vol. 31, Iss. 2, 2001-10 ,pp. : 90-98

Karger

Access to resources Recommend Favorite

Low Molecular Weight Heparin Modulates Maternal Immune Response in Pregnant Women and Mice with Thrombophilia

AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (ELECTRONIC), Vol. 73, Iss. 5, 2015-05 ,pp. : 417-427

John Wiley & Sons Inc

Access to resources Recommend Favorite

LOW‐MOLECULAR‐WEIGHT HEPARIN NOT EFFECTIVE AT PREVENTING PREGNANCY COMPLICATONS IN WOMEN WITH THROMBOPHILIAS

JOURNAL OF MIDWIFERY & WOMEN'S HEALTH, Vol. 60, Iss. 1, 2015-01 ,pp. : 106-106

John Wiley & Sons Inc

Access to resources Recommend Favorite

Harmful Medication Errors Involving Unfractionated and Low-Molecular-Weight Heparin in Three Patient Safety Reporting Programs

By Grissinger Matthew C. Hicks Rodney W. Keroack Mark A. Marella William M. Vaida Allen J.

Joint Commission Journal on Quality and Patient Safety, Vol. 36, Iss. 5, 2010-05 ,pp. : 195-202

Joint Commission Resources

Access to resources Recommend Favorite

Thromboprophylaxis with Low-Molecular- Weight Heparin: Economic Considerations

Pathophysiology of Haemostasis and Thrombosis, Vol. 30, Iss. 2, 2004-11 ,pp. : 141-145

Karger

Access to resources Recommend Favorite